Pfizer Inc. Cuts 2012 Sales Forecast, Shares Fall
NEW YORK (Reuters) - Pfizer Inc cut its sales projection for 2012, the first full year its $10 billion-a-year Lipitor cholesterol fighter faces competition from cheaper U.S. generics, sending its shares 1.5 percent lower in premarket trading.